0412-4081
2015 Issue 2
..............page:81-83
Insist on the nature of evidence-based medicine for the development of glaucoma clinical trial
Ge Jian;
Ge Jian;
..............page:84-85
Is increased choroidal thickness a risk factor for primary angle-closure glaucoma ?
Zhang Xiulan;,Huang Wenbin;
Zhang Xiulan;,Huang Wenbin;
..............page:86-88
Focus on the ethics problem in glaucoma management
Zhang Chun;,Shi Yan;,Zhang Yu;,Huang Ping;
Zhang Chun;,Shi Yan;,Zhang Yu;,Huang Ping;
..............page:89-91
..............page:92-94
shi wang mo xing xing xi bao cuo gou liu
li zuo ;, li juan juan ;
li zuo ;, li juan juan ;
..............page:94
Randomized parallel group study of 0.0015％ tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005％ latanoprost ophthalmic solution)
Ge Jian;,Li Xiaoxin;,Sun Xinghuai;,He Xiangge;,Zhang Hong;
Ge Jian;,Li Xiaoxin;,Sun Xinghuai;,He Xiangge;,Zhang Hong;
..............page:95-102
di 20 jie quan guo yan wai shang xue shu yan tao hui hui yi ji yao
zhong hua yi xue hui yan ke xue fen hui yan wai shang xue zu ;
zhong hua yi xue hui yan ke xue fen hui yan wai shang xue zu ;
..............page:102
Distribution of peak intraocular pressure in 24-hour and correlation between peak nocturnal intraocular pressure with diurnal intraocular pressure level in primary open angle glaucoma patients
Cheng Jingyi;,Sun Xinghuai;
Cheng Jingyi;,Sun Xinghuai;
..............page:103-108
A prospective randomized study of selective laser trabeculoplasty (SLT) as a replacement for medical therapy in primary open-angle glaucoma
Zhang Hongyang;,Yang Yangfan;,Xu Jiangang;,Yu Minbin;
Zhang Hongyang;,Yang Yangfan;,Xu Jiangang;,Yu Minbin;
..............page:109-114
..............page:114,160
Preliminary investigation on the safety and efficacy of Trabectome
huang ping ;, wang huai zhou ;, wu hui juan ;, sun zuo ran ;, wang shu ;, cui ying ;, qiu wei qiang ;, yang yi ;, ren ze qin ;
huang ping ;, wang huai zhou ;, wu hui juan ;, sun zuo ran ;, wang shu ;, cui ying ;, qiu wei qiang ;, yang yi ;, ren ze qin ;
..............page:115-119
Study of thioredoxin antioxidative system in lateral geniculate body of chronic intraocular hypertension rat
Chen Xinya;,Zhang Shenghai;,Wu Jihong;,Sun Xinghuai;
Chen Xinya;,Zhang Shenghai;,Wu Jihong;,Sun Xinghuai;
..............page:120-125
Efficacy of intravitreal carboplatin plus bevacizumab in refractory retinoblastoma
Hou Xianru;,Cheng Yong;,Zhang Qi;,Liang Jianhong;,Li Xiaoxin;
Hou Xianru;,Cheng Yong;,Zhang Qi;,Liang Jianhong;,Li Xiaoxin;
..............page:126-129
Protective effect of Salidroside on oxidative damage to human lens epithelial cells
Zhu Fengmei;,Zheng Guangying;,Zheng Yan;,Zhang Meng;
Zhu Fengmei;,Zheng Guangying;,Zheng Yan;,Zhang Meng;
..............page:130-135
bai nei zhang zhai chu shu hou ren gong jing zhuang ti yan ji fa xing se su xing qing guang yan yi li
zhu xue mei ;, ren ze qin ;
zhu xue mei ;, ren ze qin ;
..............page:136-137
shen jing xian wei liu bing xing he bing qing guang yan yi li
li zuo ;, wang jian rong ;, li zhong en ;
li zuo ;, wang jian rong ;, li zhong en ;
..............page:138-139
yan kuang rosai-dorfman bing yi li
wang zuo ;, liu xun ;, zhu li min ;, he yan jin ;
wang zuo ;, liu xun ;, zhu li min ;, he yan jin ;
..............page:140-141
xian tian xing yan kuang nang xing zhong wu yi li
liu cong ;, ni zuo ;, zhang pei ;, zhang wei ;, ma zhi zhong ;, wang zuo ;
liu cong ;, ni zuo ;, zhang pei ;, zhang wei ;, ma zhi zhong ;, wang zuo ;
..............page:142-143
xian tian xing shi ru tou xiao ao
jie shi yong ;, liu yang chen ;, han ying ;
jie shi yong ;, liu yang chen ;, han ying ;
..............page:144
shi ru tou ji mai luo mo bu fen que sun
he shou zhi ;
he shou zhi ;
..............page:145
Posture change and intraocular pressure fluctuation
Liu Wei;,Xing Xiaoli;,Ji Jian;
Liu Wei;,Xing Xiaoli;,Ji Jian;
..............page:146-150
Uveitic macular edema and the pharmacotherapy
Liu Xinshu;,Zhang Meifen;
Liu Xinshu;,Zhang Meifen;
..............page:151-154
Clinical evaluation of ocriplasmin as a vitreolytic agent
Li Luxi;,Du Hongjun;,Li Manhong;,Hui Yannian;
Li Luxi;,Du Hongjun;,Li Manhong;,Hui Yannian;
..............page:155-160